Medical device maker Boston Scientific says a cyberattack is causing a ‘global disruption’ to its operations
A cyberattack on U.S. medical device maker Boston Scientific is causing an ongoing “global disruption” to its operations, according to a federal regulatory filing on Wednesday, the latest healthtech giant to face a cyberattack in recent weeks.
Why It Matters
This story touches on medical, device, maker — topics readers are actively tracking. Review and add editorial context before publishing.
Key Facts
- Fact 1: Boston Scientific treats around 48 million patients a year, according to its website.
- Fact 2: Contact this reporter via encrypted message at zackwhittaker.1337 on Signal.
- Fact 3: He can be reached via encrypted message at zackwhittaker.1337 on Signal.
A cyberattack on U.S. medical device maker Boston Scientific is causing an ongoing “global disruption” to its operations, according to a federal regulatory filing on Wednesday, the latest healthtech giant to face a cyberattack in recent weeks.
The Massachusetts-based company, which makes medically implanted devices like pacemakers and defibrillators, confirmed in a filing with the U.S. Securities and Exchange Commission that on Tuesday it began experiencing “disruptions and limitations of access” to its IT systems and business applications critical for its operations. Boston Scientific said the cyberattack has affected its ability to ship and process orders, but has not said whether the disruption extends to customers with medical devices and implants.
(Original synthesis pending human/AI review — generated by the stub provider by selecting real sentences from the source material, not by writing new analysis or commentary.)
Original source: TechCrunch
Related Stories
OpenAI releases its official report on the Hugging Face breach
How do we explain OpenAI’s executive exodus?
Google’s Gemini has a branding problem, and so does the rest of AI
